Viewing Study NCT05282459


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-05-26 @ 7:49 AM
Study NCT ID: NCT05282459
Status: COMPLETED
Last Update Posted: 2025-03-20
First Post: 2022-03-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
Sponsor: Stanford University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Leukemia, Myeloid View
None Monocytic Leukemia View
Keywords: